Middlekauff H R, Stevenson W G, Stevenson L W
Department of Medicine, UCLA School of Medicine.
Circulation. 1991 Jul;84(1):40-8. doi: 10.1161/01.cir.84.1.40.
Atrial fibrillation is common in advanced heart failure, but its prognostic significance is controversial.
We evaluated the relation of atrial rhythm to overall survival and sudden death in 390 consecutive advanced heart failure patients. Etiology of heart failure was coronary artery disease in 177 patients (45%) and nonischemic cardiomyopathy or valvular heart disease in 213 patients (55%). Mean left ventricular ejection fraction was 0.19 +/- 0.07. Seventy-five patients (19%) had paroxysmal (26 patients) or chronic (49 patients) atrial fibrillation. Compared with patients with sinus rhythm, patients with atrial fibrillation did not differ in etiology of heart failure, mean pulmonary capillary wedge pressure on therapy, or embolic events but were more likely to be receiving warfarin and antiarrhythmic drugs and had a slightly higher left ventricular ejection fraction. After a mean follow-up of 236 +/- 303 days, 98 patients died: 56 (57%) died suddenly, and 36 (37%) died of progressive heart failure. Actuarial 1-year overall survival was 68%, and sudden death-free survival was 79%. Actuarial survival was significantly worse for atrial fibrillation than for sinus rhythm patients (52% versus 71%, p = 0.0013). Similarly, sudden death-free survival was significantly worse for atrial fibrillation than for sinus rhythm patients (69% versus 82%, p = 0.0013). By Cox proportional hazards model, pulmonary capillary wedge pressure on therapy, left ventricular ejection fraction, coronary artery disease, and atrial fibrillation were independent risk factors for total mortality and sudden death. For patients who had pulmonary capillary wedge pressure of less than 16 mm Hg on therapy, atrial fibrillation was associated with poorer 1-year survival (44% versus 83%, p = 0.00001); however, in the high pulmonary capillary wedge pressure group, atrial fibrillation did not confer an increased risk (58% versus 57%).
Atrial fibrillation is a marker for increased risk of death, especially in heart failure patients who have lower filling pressures on vasodilator and diuretic therapy. Whether aggressive attempts to maintain sinus rhythm will reduce this risk is unknown.
心房颤动在晚期心力衰竭中很常见,但其预后意义存在争议。
我们评估了390例连续的晚期心力衰竭患者的心房节律与总生存率和心源性猝死之间的关系。心力衰竭的病因在177例患者(45%)中为冠状动脉疾病,在213例患者(55%)中为非缺血性心肌病或心脏瓣膜病。平均左心室射血分数为0.19±0.07。75例患者(19%)有阵发性(26例)或慢性(49例)心房颤动。与窦性心律患者相比,心房颤动患者在心力衰竭病因、治疗时的平均肺毛细血管楔压或栓塞事件方面无差异,但更可能接受华法林和抗心律失常药物治疗,且左心室射血分数略高。平均随访236±303天后,98例患者死亡:56例(57%)心源性猝死,36例(37%)死于进行性心力衰竭。1年总生存率的精算值为68%,无心脏性猝死生存率为79%。心房颤动患者的精算生存率显著低于窦性心律患者(52%对71%,p = 0.0013)。同样,心房颤动患者的无心脏性猝死生存率也显著低于窦性心律患者(69%对82%,p = 0.0013)。通过Cox比例风险模型,治疗时的肺毛细血管楔压、左心室射血分数、冠状动脉疾病和心房颤动是总死亡率和心源性猝死的独立危险因素。对于治疗时肺毛细血管楔压低于16 mmHg的患者,心房颤动与较差的1年生存率相关(44%对83%,p = 0.00001);然而,在高肺毛细血管楔压组中,心房颤动并未增加风险(58%对57%)。
心房颤动是死亡风险增加的一个标志,尤其是在接受血管扩张剂和利尿剂治疗时充盈压较低的心力衰竭患者中。积极尝试维持窦性心律是否会降低这种风险尚不清楚。